Supplemental Methods and Results
with the Declaration of Helsinki. Investigators performing laboratory studies were blinded as to patient number and time of observation.
Cell and microparticles count in SF
SF was collected in sterile Vacutainer tubes containing 0.18% K 3 EDTA and an aliquot was incubated with hyaluronidase (250 U/ml at 37°C for 10 min) to allow accurate cell count [2].
Ten μl SF was added to 190 μL of Stromatol® solution (Mascia Brunelli srl, Milan, Italy) and total cell number was counted by optical microscopy using a Bürker chamber (Neuroprobe Inc, Gaithersburg, MD, USA) with a 40x objective. Differential count was determined in smears of cytocentrifuged, hyaluronidase-treated SF after May-Grünwald staining [3].
In vitro co-culture experiments
In selected experiments, platelets were co-cultured with FLS in the presence of HA (100, 500 and 1000 μg/ml), or of a blocking anti-CD44 antibody (Thermo Scientifics, Waltham, MA USA) (10 g/ml), or of a blocking anti-P-selectin antibody (Monoclonal Mouse IgG1 Clone #9E1, R&D system, Inc., Minneapolis, USA) (20g/ml), or of an isotype-control IgG.
In order to establish the effective concentrations of the blocking antibodies, we performed preliminary studies. The inhibitory effect of different concentrations of the anti-P-selectin antibody on P-selectin expression by platelets activated with ADP or TRAP-6 was assessed by flow cytometry. The inhibitory effect was maximal at 20μg/ml and this concentration was chosen for subsequent experiments.
The effect anti-CD44 blocking antibody at a concentration largely used in the literature (10μg/ml)
[4], was tested in FLS adhesion assay on fibrinogen and found to be effective in reducing FLS adhesion.
Results
Comparing P-selectin expression on platelets prior 24h incubation (basal) vs platelets after 24h incubation in wells without FLS (our control), we observed that P-selectin exposure tended to decrease, although not significantly ( Figure 1 ).
Figure 1. P-selectin expression on platelets before and after 24h incubation in control wells (without FLS). p=ns
We examined the possible role of platelets in the accumulation of MMP-2 in SF of OA patients by in vitro co-incubation experiments using FLS or lympho-monocytes, the two most abundant cell type present in OA SF. Our in vitro co-incubation experiments demonstrated that MMP-2 production by FLS was significantly enhanced in the presence of platelets while co-incubation of platelets with lympho-monocytes, isolated as previously described Values are reported as mean±SEM. 
